28-5250
塩化ストロンチウム 六水和物
SAJ first grade, ≥98.0%
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
化学式:
SrCl2 · 6H2O
CAS番号:
分子量:
266.62
UNSPSC Code:
12352302
PubChem Substance ID:
EC Number:
233-971-6
MDL number:
Assay:
≥98.0%
Grade:
SAJ first grade
Form:
solid
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1
保管分類
11 - Combustible Solids
wgk
WGK 1
ppe
dust mask type N95 (US), Eyeshields, Gloves
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
名称等を表示すべき危険物及び有害物
ishl_indicated
名称等を通知すべき危険物及び有害物
ishl_notified
28-5250-5-500G-J: + 28-5250-2-25G-J:
jan
Fan Yang et al.
Stem cells (Dayton, Ohio), 29(6), 981-991 (2011-05-13)
Strontium ranelate is a newly approved drug that can reduce the risk of vertebral fracture, which is attributed to its dual function in increasing the bone formation and decreasing the bone resorption. Strontium-containing hydroxyapatite was also demonstrated to stimulate the
Jun-Woo Kim et al.
Journal of assisted reproduction and genetics, 29(12), 1393-1396 (2012-11-28)
To report a live birth resulting after strontium chloride (SrCl(2)) oocyte activation in a couple with complete fertilization failure or low fertilization rates following intracytoplasmic sperm injection (ICSI) of frozen-thawed testicular spermatozoa. The couple underwent ICSI of frozen-thawed testicular spermatozoa.
Karen Versieren et al.
Reproductive biomedicine online, 21(6), 769-775 (2010-11-06)
Parthenogenetic reconstruction is one major strategy to create patient-specific stem cells. The aim of this study was to find the best artificial activation protocol for parthenogenetic activation of mouse and human oocytes comparing different methods. In a first set of
Hengchao Liu et al.
Oncology reports, 28(5), 1894-1902 (2012-08-28)
The aim of this study was to investigate the radiosensitizing effects of arsenic trioxide (As2O3) on MCF-7 human breast cancer cells irradiated with 89 strontium chloride (89SrCl2). The 50% inhibitory concentration (IC50) was calculated from results of an MTT assay.
Salil Vengalil et al.
Current opinion in supportive and palliative care, 6(3), 310-315 (2012-06-20)
Bone metastases in prostate cancer are often the cause of significant morbidity in patients with castrate-resistant disease, and several studies have shown significant pain palliation with systemic radionuclide treatment. The purpose of this review is to discuss the place of
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）